The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“It has been shown that genetic manipulation of cancer cells causing isoform switching of PKM2 to PKM1 effectively reversed the Warburg effect, which suggests that expression of PKM2 is required for aerobic glycolysis [55].”
BackgroundCancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,443
The emerging mechanisms of isoform-specific PI3K signalling
Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., & Bilanges, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2882 · Cited by 1,767 · cited 1×
“Studies have shown that PI3K signaling pathways have a role in many cellular processes such as metabolism, inflammation, cell survival, motility and cancer progression [19].”
BackgroundBonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A., & Semenza, G. L. (2011) · Cell · doi:10.1016/j.cell.2011.03.054 · Cited by 1,463
Mahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385
HIF-1: upstream and downstream of cancer metabolism
Semenza, G. L. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,372
Tisdale, M. J. (2009) · Physiological Reviews · doi:10.1152/physrev.00016.2008 · Cited by 1,192
Hudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., & Abraham, R. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7004-7014.2002 · Cited by 1,186
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
Manalo, D. J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B. D., Ye, S. Q., Garcia, J. G. N., & Semenza, G. L. (2005) · Blood · doi:10.1182/blood-2004-07-2958 · Cited by 1,154
Links between metabolism and cancer
Dang, C. V. (2012) · Genes & Development · doi:10.1101/gad.189365.112 · Cited by 1,100
PI3K/AKT signaling pathway and cancer: An updated review
Martini, M., De Santis, M. C., Braccini, L., Gulluni, F., & Hirsch, E. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.912836 · Cited by 1,020
Lu, H., Forbes, R. A., & Verma, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202487200 · Cited by 837
mtDNA mutations increase tumorigenicity in prostate cancer
Petros, J. A., Baumann, A. K., Ruiz-Pesini, E., Amin, M. B., Sun, C. Q., Hall, J., Lim, S., Issa, M. M., Flanders, W. D., Hosseini, S. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408894102 · Cited by 836
The monocarboxylate transporter family—Role and regulation
Halestrap, A. P., & Wilson, M. C. (2012) · IUBMB Life · doi:10.1002/iub.572 · Cited by 741
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
Michelakis, E. D., Webster, L., & Mackey, J. R. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604554 · Cited by 656
Seyfried, T. N., & Shelton, L. M. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-7 · Cited by 644
Hypoxia and mitochondrial oxidative metabolism
Solaini, G., Baracca, A., Lenaz, G., & Sgarbi, G. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.02.011 · Cited by 608
The molecular biology of cancer
Bertram, J. S. (2000) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(00)00007-8 · Cited by 585
Sonveaux, P., Copetti, T., De Saedeleer, C. J., Végran, F., Verrax, J., Kennedy, K. M., Moon, E. J., Dhup, S., Danhier, P., Frérart, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033418 · Cited by 536
Semenza, G. L. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.08.006 · Cited by 483
Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation
Holness, M. J., & Sugden, M. C. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311143 · Cited by 479
HIF-1 and HIF-2 Transcription Factors - Similar but Not Identical
Loboda, A., Jozkowicz, A., & Dulak, J. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0067-2 · Cited by 477 · cited 4×
“Conversely, the a subunits comprise of three different isoforms, HIF-1a, HIF-2a and HIF-3a [28], which are regulatory subunits that individual to the oxygen response pathway [27] and are regulated by regulated by the cellular O2 concentration [29].”
BackgroundInfluentialRegulation of cancer cell metabolism by hypoxia-inducible factor 1
Semenza, G. L. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.009 · Cited by 469
Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain
Bergeron, M., Gidday, J. M., Yu, A. Y., Semenza, G. L., Ferriero, D. M., & Sharp, F. R. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200009)48:3<285::aid-ana2>3.0.co;2-8 · Cited by 432
Activation of the HIF pathway in cancer
Maxwell, P. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00193-3 · Cited by 426
Glucose transporters in cancer metabolism
Adekola, K., Rosen, S. T., & Shanmugam, M. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328356da72 · Cited by 382
Rethinking the Warburg Effect with Myc Micromanaging Glutamine Metabolism
Dang, C. V. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3556 · Cited by 379
Chen, J.-Q., & Russo, J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.06.004 · Cited by 327
Hypoxia signalling controls metabolic demand
Brahimi-Horn, M. C., Chiche, J., & Pouysségur, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.003 · Cited by 298
The Warburg Effect: Why and How Do Cancer Cells Activate Glycolysis in the Presence of Oxygen?
Lopez-Lazaro, M. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008783961932 · Cited by 285
HIF-1 mediates the Warburg effect in clear cell renal carcinoma
Semenza, G. L. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9081-2 · Cited by 281
GLYCOGEN FORMATION IN THE LIVER FROM d- AND l-LACTIC ACID
Cori, C. F., & Cori, G. T. (1929) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83822-4 · Cited by 264
The Warburg hypothesis fifty years later
Weinhouse, S. (1976) · Zeitschrift f�r Krebsforschung und Klinische Onkologie · doi:10.1007/bf00284370 · Cited by 228
Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Gatter, K. C., & Harris, A. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9501 · Cited by 221
PI3K/Akt-mediated regulation of p53 in cancer
Abraham, A. G., & O’Neill, E. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140070 · Cited by 221
MicroRNA-125b Induces Metastasis by Targeting STARD13 in MCF-7 and MDA-MB-231 Breast Cancer Cells
Tang, F., Zhang, R., He, Y., Zou, M., Guo, L., & Xi, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035435 · Cited by 203
Moulton, C. J., Valentine, R. J., Layman, D. K., Devkota, S., Singletary, K. W., Wallig, M. A., & Donovan, S. M. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-1 · Cited by 201
Luo, W., & Semenza, G. L. (2011) · Oncotarget · doi:10.18632/oncotarget.299 · Cited by 190
Wu, C., Ho, Y., Tsai, C., Wang, Y., Tseng, H., Wei, P., Lee, C., Liu, R., & Lin, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24189 · Cited by 159
Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect
Weljie, A. M., & Jirik, F. R. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.009 · Cited by 155
Coming up for air: HIF-1 and mitochondrial oxygen consumption
Simon, M. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.007 · Cited by 136
Singh, K. K., Kulawiec, M., Still, I. H., Desouki, M. M., Geradts, J., & Matsui, S. (2005) · Gene · doi:10.1016/j.gene.2005.03.027 · Cited by 133
Marondedze, C., Turek, I., Parrott, B., Thomas, L. A., Janković, B. R., Lilley, K. S., & Gehring, C. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-1 · Cited by 121
He, M., Wang, Q.-Y., Yin, Q.-Q., Tang, J., Lu, Y., Zhou, C.-X., Duan, C.-W., Hong, D.-L., Tanaka, T. T., Chen, G.-Q., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.130 · Cited by 94
Minet, E., Michel, G., Remacle, J., & Michiels, C. (2000) · International Journal of Molecular Medicine · doi:10.3892/ijmm.5.3.253 · Cited by 92
PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting
Ciuffreda, L., Falcone, I., Incani, U. C., Curatolo, A. D., Conciatori, F., Matteoni, S., Vari, S., Vaccaro, V., Cognetti, F., & Milella, M. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.07.002 · Cited by 88
Hypoxia-inducible factor (HIF) network: insights from mathematical models
Cavadas, M. A. S., Nguyen, L. K., & Cheong, A. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-42 · Cited by 84
Targets of 3-Bromopyruvate, A New, Energy Depleting, Anticancer Agent
Dell’Antone, P. (2009) · Medicinal Chemistry · doi:10.2174/157340609790170551 · Cited by 59
HIF-1 is the Commander of Gateways to Cancer
Ma, N. (2011) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000054 · Cited by 41
The Warburg Effect returns to the cancer stage
Zhivotovsky, B., & Orrenius, S. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.12.003 · Cited by 38
Ren, B.-F., Deng, L., Wang, J., Zhu, Y.-P., Li, W., & Zhou, Q. (2007) · Joint Bone Spine · doi:10.1016/j.jbspin.2007.05.012 · Cited by 33
The Role of Akt Pathway Signaling in Glucose Metabolism and Metabolic Oxidative Stress
Simons, A. L., Orcutt, K. P., Madsen, J. M., Scarbrough, P. M., & Spitz, D. R. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-397-4_2 · Cited by 29
(2003) · CRC Press eBooks · doi:10.1201/b14819-12 · Cited by 29
Cited by
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
Muz, B., de la Puente, P., Azab, F., & Azab, A. K. (2015) · Hypoxia · doi:10.2147/hp.s93413 · Cited by 2,066
“41 Hypoxia-independent HIF-α regulation occurs in response to cytokines, lipopolysaccharides, and growth factors, mediated by PI3K/AKT/mTOR, 29,30 MAPK, 41 and NF ĸ B pathways.”
BackgroundEpidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
Wee, P., & Wang, Z. (2017) · Cancers · doi:10.3390/cancers9050052 · Cited by 2,027
“AKT is one of the main drivers of the Warburg effect, as it increases glucose uptake through the upregulation of glucose transporters [299,300].”
BackgroundCardiomyocyte maturation: advances in knowledge and implications for regenerative medicine
Karbassi, E., Fenix, A., Marchiano, S., Muraoka, N., Nakamura, K., Yang, X., & Murry, C. E. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0331-x · Cited by 755
Regulation of Immunity and Inflammation by Hypoxia in Immunological Niches
Taylor, C. T., & Colgan, S. P. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.103 · Cited by 713
Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
Sun, Q., Hong, Z., Zhang, C., Wang, L., Han, Z., & Ma, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01522-4 · Cited by 598
“The Warburg effect refers to the specific glycolysis metabolism which causes cell proliferation in tumours.(180) Metabolisms such as hypoxic TME (O2 pressure <10mmHg) may induce immunosuppression, immunoresistance, and multiple biological processes.”
Background
Metadata
- Authors
- Courtnay, R., Ngo, D. C., Malik, N., Ververis, K., Tortorella, S. M., & Karagiannis, T. C.
- Venue
- Molecular Biology Reports
- Published
- 2015-02-18
- Volume
- 42
- Issue
- 4
- Pages
- 841-851
- ISSN
- 0301-4851 (ISSN-L)
- 1573-4978
- OpenAlex
- W2075162479
- Cited by
- 567
- References
- 60
- FWCI
- 9.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.